Zimmer Biomet Holdings (ZBH) promoted Gary Campbell to President, Americas, and Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery, effective October 1, the company said Tuesday.
Bradley Kessler was also promoted to President, Americas - Robotics, Technology and Data. All three will report to Chairman, President and CEO Ivan Tornos.
Kevin Thornal, Group President, Global Businesses and the Americas, will leave the company on September 30, 2026, following a transition period.
Zimmer Biomet also reiterated its full-year 2026 adjusted earnings outlook of $8.47 to $8.59 per share on revenue growth of 3.9% to 4.9%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.